HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.

AbstractINTRODUCTION:
Over the past few decades it has been recognized that antiphospholipid antibodies are associated with pregnancy loss. Other placenta-mediated pregnancy complications have also been associated with the presence of antiphospholipid antibodies. Most studies have measured antiphospholipid antibodies near the time of the event investigated.
OBJECTIVES:
To investigate the association of antiphospholipid antibodies and a history of intrauterine fetal death (IUFD) in a case-control design.
MATERIALS AND METHODS:
A case-control study of 105 women with a history of IUFD after 22 gestational weeks and 262 controls with live births. The prevalence of lupus anticoagulant, anticardiolipin- and anti-β2-glycoprotein 1 antibodies were measured 3-18years after the event of IUFD.
RESULTS:
Total 9.5% of women with a history of IUFD and 5.0% of controls had at least one positive test for antiphospholipid antibodies (OR 2.0; 95% confidence interval (CI) 0.9-4.8). Women with a history of IUFD were significantly more often positive for lupus anticoagulant compared to controls (OR 4.3; 95% CI 1.0-18.4). The association of lupus anticoagulant with a history of IUFD was confined to women positive for other antiphospholipid antibodies in addition to lupus anticoagulant. Being positive for anti-β2-glycoprotein 1 or anticardiolipin antibodies alone was not significantly associated with a history of IUFD.
CONCLUSIONS:
Women with a history of IUFD after 22 gestational weeks were more often lupus anticoagulant positive. The association was confined to women with multiple positivity for antiphospholipid antibodies, although firm conclusions on the importance of multiple positivity cannot be made from this study.
AuthorsLinda Björk Helgadottir, Finn Egil Skjeldestad, Anne Flem Jacobsen, Per Morten Sandset, Eva-Marie Jacobsen
JournalThrombosis research (Thromb Res) Vol. 130 Issue 1 Pg. 32-7 (Jul 2012) ISSN: 1879-2472 [Electronic] United States
PMID22178574 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Anticardiolipin
  • Antibodies, Antiphospholipid
  • Lupus Coagulation Inhibitor
  • beta 2-Glycoprotein I
Topics
  • Adult
  • Antibodies, Anticardiolipin (adverse effects, blood, immunology)
  • Antibodies, Antiphospholipid (adverse effects, blood, immunology)
  • Case-Control Studies
  • Female
  • Fetal Death (blood, etiology, immunology)
  • Humans
  • Lupus Coagulation Inhibitor (adverse effects, blood, immunology)
  • Pregnancy
  • beta 2-Glycoprotein I (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: